Transdermal drug delivery treatment for overactive bladder.
about
Treatment choice, duration, and cost in patients with interstitial cystitis and painful bladder syndromeWomen's experience with severe overactive bladder symptoms and treatment: insight revealed from patient focus groups.Safety and tolerability profiles of anticholinergic agents used for the treatment of overactive bladder.Predictors of oral health after spinal cord injury.Synergistic effect of iontophoresis and chemical enhancers on transdermal permeation of tolterodine tartrate for the treatment of overactive bladder.
P2860
Transdermal drug delivery treatment for overactive bladder.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Transdermal drug delivery treatment for overactive bladder.
@ast
Transdermal drug delivery treatment for overactive bladder.
@en
type
label
Transdermal drug delivery treatment for overactive bladder.
@ast
Transdermal drug delivery treatment for overactive bladder.
@en
prefLabel
Transdermal drug delivery treatment for overactive bladder.
@ast
Transdermal drug delivery treatment for overactive bladder.
@en
P2093
P2860
P1476
Transdermal drug delivery treatment for overactive bladder.
@en
P2093
G Willy Davila
Jonathan S Starkman
Roger R Dmochowski
P2860
P304
P356
10.1590/S1677-55382006000500003
P577
2006-09-01T00:00:00Z